RE: RNS - Clinical data release16 Jun 2022 00:20
It's not on the news - I do not think. It's based on the expectation of the Fed hiking interest rate, which affects discount rate and therefore the valuation of growth stocks like Vrci.
But once again, I get it if Tesla and the likes are affected, but Vrci is hovering around £40mn MV which is an utter joke for its IP. We are not a billion dollar valued company.
Enough of my rant.
Just as easy it went down, upon good news, hopefully it can go up, upon commercialisation traction.
Chris Mills must be tempted to privatise this given its current valuation.
Just imagine that this company is offered to a venture capital right now - what type of valuation would it worth? Defo not £40mn - for sure. My guess, £100mn+